Us Bancorp \De\ United Therapeutics Corp Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in United Therapeutics Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 1,756 shares of UTHR stock, worth $606,943. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,756
Previous 1,779
1.29%
Holding current value
$606,943
Previous $637,000
2.83%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding UTHR
# of Institutions
696Shares Held
60.8MCall Options Held
194KPut Options Held
292K-
Wealthfront Advisers LLC18.3MShares$6.33 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.89 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.54 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.1 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$988 Million15.42% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $15.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...